Treatment Patterns and Clinical Outcomes among Advanced NSCLC Patients with EGFR exon 20 Insertion Mutations in China

被引：0
|
作者：
Wang, Y. [1 ]
Lin, H. M. [2 ]
Ning, N. [3 ]
Du, F. [4 ]
Gao, X. [3 ]
Dong, Q. [2 ]
Yang, G. [1 ]
Xu, H. [5 ]
He, Y. [6 ]
Zhou, C. [6 ]
机构：
[1] Natl Clin Res Ctr Canc, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China
[2] Takeda Dev Ctr Amer Inc, Lexington, MA USA
[3] OPEN Hlth, Bernardsville, NJ USA
[4] OPEN Hlth, Shanghai, Peoples R China
[5] Chinese Acad Med Sci & Peking Uni, Canc Hosp, Natl Clin Res Ctr Canc, Dept Comprehens Oncol,Natl Canc Ctr, Beijing, Peoples R China
[6] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer in China; Treatment patterns; Clinical outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP10.01-17
引用
收藏
页码：S609 / S609
页数：1
相关论文
共 50 条
  • [1] Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations
    Hu, Meng
    Zhong, Congying
    Wang, Jiabing
    Chen, JinQin
    Zhou, Tao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study
    Qin, Yi
    Long, Yaling
    Tang, Yuan
    Tian, Yuke
    Li, Juan
    Duan, Ping
    Luo, Jieyan
    Yu, Min
    Li, Yanying
    Zhou, Xiaojuan
    Wang, Ke
    Gong, Youling
    Peng, Feng
    Zhu, Jiang
    Liu, Yongmei
    Zhou, Lin
    Lu, You
    Huang, Meijuan
    CANCER SCIENCE, 2023, 114 (06) : 2552 - 2559
  • [3] Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphoma
    Nisbett, Alnecia R.
    Yang, Xiaoqin
    Squires, Patrick
    Gautam, Santosh
    Desai, Kaushal
    Raut, Monika
    Nahar, Akash
    FUTURE ONCOLOGY, 2022, 18 (32) : 3623 - 3636
  • [4] Successful Treatment of Lung Adenocarcinoma with Epidermal Growth Factor Receptor Compound Mutations Involving Exon 19 Deletion and Exon 20 Insertion by Afatinib
    Ikeuchi, Tomoyuki
    Tokuyasu, Hirokazu
    Ishikawa, Soichiro
    INTERNAL MEDICINE, 2019, 58 (01) : 101 - 104
  • [5] Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and MET Exon 14 Skipping Mutations: A Descriptive Analysis From the US
    Kolaei, Fatemeh Asad Zadeh Vosta
    Cai, Beilei
    Kanakamedala, Hemanth
    Kim, Julia
    Doban, Vitalii
    Zhang, Shiyu
    Shi, Michael
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China
    Zhang, Jingdong
    Wang, Guangyu
    Xie, Xianhe
    Pan, Wensheng
    Dong, Qian
    Zhang, Nianhai
    Dong, Jie
    Zhou, Li
    Zhou, Chan
    Li, Jinnan
    Segall, Grace
    Zhang, Yanqiao
    FUTURE ONCOLOGY, 2025,
  • [7] Treatment patterns and clinical outcomes among patients <65 years with a worsening heart failure event
    Butler, Javed
    Yang, Mei
    Sawhney, Baanie
    Chakladar, Sreya
    Yang, Lingfeng
    Djatche, Laurence M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (08) : 1334 - 1342
  • [8] Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting
    Nadler, E.
    Pavilack, M.
    Clark, J.
    Espirito, J.
    Fernandes, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S601 - S601
  • [9] Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations
    Klughammer, Barbara
    Brugger, Wolfram
    Cappuzzo, Federico
    Ciuleanu, Tudor
    Mok, Tony
    Reck, Martin
    Tan, Eng Huat
    Delmar, Paul
    Klingelschmitt, Gaelle
    Yin, Anny-Yue
    Spleiss, Olivia
    Wu, Lin
    Shames, David S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : 545 - 555
  • [10] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Kim, Seung Tae
    Sung, Jae Sook
    Jo, Uk Hyun
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    MEDICAL ONCOLOGY, 2013, 30 (01)
12345